Chinese pharmaceutical company Chengdu Easton Biopharmaceuticals Co Ltd plans to raise 1.3 billion yuan ($193 million) in an initial public offering (IPO) on the Nasdaq-style STAR Market of the Shanghai Stock Exchange, according to a company filing.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
